Intelligent Bio Solutions (INBS) announced it has secured a major new contract with one of the United Kingdom’s largest industrial service providers. “Securing this account highlights the expanding market confidence in our technology and its growing role in transforming drug testing across some of the world’s largest industrial operators,” said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. “Each new enterprise adoption validates our value proposition, strengthens our commercial trajectory, and expands recurring consumables revenue potential.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions Approves Incentive Plan Amendment
- Intelligent Bio Solutions Updates FDA Clearance Timeline
- Intelligent Bio advances preparations, provides timeline for IFDSS for codeine
- Intelligent Bio Solutions Extends Warrant Termination Date
- FDA Requests More Info from Intelligent Bio Solutions